Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.38 |
| ▸ | FDPS | P14324 | 2/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9578903 | 1.00 | ALOX15 (0.50) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL7933532 | 1.00 | ALOX15 (0.50) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL7933530 | 1.00 | ALOX15 (0.50) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL1150421 | 0.87 | ALOX15 (0.49) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL523093 | 0.87 | ALOX15 (0.49) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL523092 | 0.87 | ALOX15 (0.49) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL1150423 | 0.87 | ALOX15 (0.49) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL11861700 | 0.87 | ALOX15 (0.57) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL11861697 | 0.87 | ALOX15 (0.57) | ALOX15ALDH1A1USP2TSHRFNTA | |
| SCHEMBL11850606 | 0.86 | ALOX15 (0.45) | ALOX15ALDH1A1USP2TSHRFNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2935176-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | claimed |
| EP-2935176-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP Assets B.V. (NL) | 2015-10-28 | — | — | EP | claimed |
| WO-2014096066-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS B.V. (NL) | 2014-06-26 | — | — | WO | claimed |
| JP-1016738-A | — | — | None | — | — | JP | disclosed |
| EP-2935176-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | disclosed |
| EP-2935176-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP Assets B.V. (NL) | 2015-10-28 | — | — | EP | disclosed |
| WO-2014096066-A1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS B.V. (NL) | 2014-06-26 | — | — | WO | disclosed |
| EP-0295531-B1 | HYDROGENATION PROCESS | F. HOFFMANN-LA ROCHE AG (CH) | 1993-03-24 | — | — | EP | disclosed |
| US-5132464-A | For unsaturated ketones, Raney nickel catalyst or platinum catalyst on calcium carbonate or on carbon | HOFFMANN-LA ROCHE, INC. (US) | 1992-07-21 | — | — | US | disclosed |
| US-4882441-A | VITAMIN E DERIVATIVES | HOFFMANN-LA ROCHE INC. (US) | 1989-11-21 | — | — | US | disclosed |
| US-4879395-A | Vitamin E intermediate | HOFFMANN-LA ROCHE INC. (US) | 1989-11-07 | — | — | US | disclosed |
| US-4853472-A | Vitamin E intermediates | HOFFMANN-LA ROCHE INC. (US) | 1989-08-01 | — | — | US | disclosed |
| EP-0295531-A2 | Hydrogenation process | F. HOFFMANN-LA ROCHE AG (CH) | 1988-12-21 | — | — | EP | disclosed |
| US-4789750-A | 2-(trimethyl-tridecenyl)-tetramethylchroman intermediates for vitamin E | HOFFMAN-LA ROCHE INC. (US) | 1988-12-06 | — | — | US | disclosed |
| EP-0283946-A1 | Novel intermediates useful in preparing vitamin E | F. HOFFMANN-LA ROCHE AG (CH) | 1988-09-28 | — | — | EP | disclosed |